Erratum for “HLA-B Correlates With Unique Disease Manifestations in Juvenile Spondyloarthritis: A Retrospective Cohort Analysis”
-
September 15, 2026
Clinical Report: Erratum for HLA-B Correlates With Unique Disease Manifestations
Background
Understanding the genetic correlates of juvenile spondyloarthritis is crucial for accurate diagnosis and management. HLA-B typing can provide insights into disease manifestations.
Data Highlights
No numerical data is presented in this erratum.
Key Findings
- Typesetting error identified in Table 2 of the original study.
- Superscript “c” was incorrectly assigned and has been corrected.
- The error did not affect the overall results or conclusions of the study.
- The erratum was published to maintain the accuracy of the scientific record.
Clinical Implications
Clinicians should be aware of the corrected data to ensure accurate interpretation of the study's findings.
Conclusion
The erratum serves to correct a minor detail in the published study.
Related Resources & Content
- Bikas, D.V., Brandon, T.G., Newby, B.N., Weiss, P.F., ACR Open Rheumatology, 2026 -- HLA-B Correlates With Unique Disease Manifestations in Juvenile Spondyloarthritis: A Retrospective Cohort Analysis
- Clinical Rheumatology — Erratum: Reduced paraoxonase-1 activity is linked to increased oxylipins and small airways disease in individuals with rheumatoid arthritis
- Blood Cancer Journal — Author Correction: Clonal hematopoiesis in patients with rheumatoid arthritis
- Clinical Rheumatology — Correction: A Retrospective Study on the Natural History of Incident Dermatomyositis and Polymyositis in Adult and Juvenile Patients Utilizing Real-World Data
- Clinical Rheumatology — Erratum: Clinical Characteristics and Risk Factors for Central Nervous System Involvement in Primary Sjögren’s Syndrome
- https://assets.contentstack.io/v3/assets/bltee37abb6b278ab2c/blt4e307b8933591fa5/jia-guidelines-summary-2026.pdf
- Classification Criteria for Axial Disease in Youth with Juvenile Spondyloarthritis - PMC
- Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial - PMC
- Clinical Impact of HLA‐B27 on Juvenile Idiopathic Arthritis: Eighteen Years of Follow‐up in the Population‐Based Nordic Juvenile Idiopathic Arthritis Cohort - Ekelund - 2025 - ACR Open Rheumatology - Wiley Online Library
Based on findings from:
Correction to “HLA-B Associates With Distinct Disease Expression in Juvenile Spondyloarthritis: A Retrospective Cohort Study”
Acr Open Rheumatology, 2026.
https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/acr2.90158
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
